Financhill
Back

Checkpoint Therapeutics Quote, Financials, Valuation and Earnings

Checkpoint Therapeutics Price Quote

$4.02
+0.27 (+7.2%)
(Updated: November 25, 2024 at 5:50 PM ET)

Checkpoint Therapeutics Key Stats

Sell
46
Checkpoint Therapeutics (CKPT) is a Sell

Day range:
$3.46 - $3.81
52-week range:
$1.36 - $3.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
836.7K
Avg. volume:
1.1M
1-year change:
79.43%
Market cap:
$183.1M
Revenue:
$103K
EPS:
$-1.84

How Much Does Checkpoint Therapeutics Make?

Data Unavailable

Is Checkpoint Therapeutics Growing As A Company?

Data Unavailable

Checkpoint Therapeutics Stock Price Performance

What Is Checkpoint Therapeutics 52-Week High & Low?

Checkpoint Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Checkpoint Therapeutics?

Is Checkpoint Therapeutics Cash Flow Positive?

  • What Is CKPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$30.8M
  • What Is Checkpoint Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $33.7M
  • What Is Checkpoint Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Checkpoint Therapeutics Return On Invested Capital

Data Unavailable

Checkpoint Therapeutics Earnings Date & Stock Price

Checkpoint Therapeutics Competitors

Checkpoint Therapeutics Dividend Yield

Checkpoint Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 17.00
Upside from Last Price: 353.33%

Major Shareholders

  • How many CKPT shares are owned by institutional investors?
    13.7M CKPT shares are owned by institutional investors
  • How many CKPT shares are owned by insiders?
    3.2M CKPT shares are owned by insiders